Novavax Inc (NVAX)

[Billcoln]

There may be a secondary but I doubt it would come prior to Novavax gaining the recognition of it's greatly increased value from the news about to get released over the next week. We could also see RSV Maternal get outside funding from PATH or elsewhere. Let's see how the next week plays out before we discuss funding.

One factor that has not been appreciated is the fact that Novavax with the breath and size of the recent Adult RSV trial has essentially Aced a Phase 3 Clinical Trial. Even the doubting Lobster was blown away by this successful trial. This company is clearly going to bring to market a very large vaccine. Bill
Sentiment: Strong Buy